15.02.2013 Views

world cancer report - iarc

world cancer report - iarc

world cancer report - iarc

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Agent or substance Cancer site/<strong>cancer</strong><br />

IARC Group 1: Carcinogenic to humans<br />

X-rays and gamma-radiation Various – all sites<br />

Solar radiation Skin<br />

Radon-222 and its decay products Lung<br />

Radium-224, -226, -228 and their decay products Bone<br />

Thorium-232 and its decay products Liver, including<br />

haemangiosarcoma; leukaemia<br />

Radioiodines (including iodine-131) Thyroid<br />

Plutonium-239 and its decay products (aerosols) Lung, liver, bone<br />

Phosphorus-32 Leukaemia<br />

Neutrons Various<br />

Alpha (α) particle-emitting radionuclides Various<br />

Beta (β) particle-emitting radionuclides Various<br />

IARC Group 2A: Probably carcinogenic to humans<br />

Sunlamps and sun beds, use of Skin<br />

Ultraviolet radiation Skin<br />

Table 2.15 Various forms and sources of radiation that are carcinogenic to humans (IARC Group 1) or probably<br />

carcinogenic to humans (IARC Group 2A).<br />

Frequency Class Type of device or service<br />

30 - 300 kHz LF (low) LF broadcast and long-range radio<br />

300 - 3,000 kHz MF (medium) AM radio, radio navigation, ship-to-shore<br />

3 - 30 MHz HF (high) CB radio, amateurs, HF radio communications<br />

and broadcast<br />

30 - 300 MHz VHF (very high) FM radio, VHF TV, emergency services<br />

300 - 3,000 MHz UHF (ultra high) UHF TV, paging, mobile telephones,<br />

amateur radios<br />

3 - 30 GHz SHF (super high) Microwaves, satellite communications,<br />

radar, point to point microwave<br />

communications<br />

30 - 300 GHz EHF (extremely high) Radar, radioastronomy, short-link<br />

microwave communications<br />

Table 2.16 Radiofrequency range: class and type of device or service.<br />

52 The causes of <strong>cancer</strong><br />

Fig. 2.36 The Chernobyl nuclear power plant following<br />

the accident in 1986.<br />

Knowledge of associated health effects<br />

comes from epidemiological study of hundreds<br />

of thousands of exposed persons,<br />

including the survivors of the atomic<br />

bombings in Hiroshima and Nagasaki,<br />

patients irradiated for therapeutic purposes,<br />

populations with occupational exposures<br />

and people exposed as a result of<br />

accidents. These data are complemented<br />

by findings from large-scale animal experiments<br />

carried out to evaluate the effects<br />

of different types of radiation, taking<br />

account of variation in dose and exposure<br />

pattern, and with reference to cellular and<br />

molecular endpoints. Such experiments<br />

are designed to characterize the mechanisms<br />

of radiation damage, repair and carcinogenesis.<br />

Survivors of the atomic bombings in<br />

Hiroshima and Nagasaki were exposed<br />

primarily to γ-rays. Amongst these people,<br />

dose-related increases in the risk of<br />

leukaemia, breast <strong>cancer</strong>, thyroid <strong>cancer</strong><br />

and a number of other malignancies have<br />

been observed. Increased frequency of<br />

these same malignancies has also been<br />

observed among <strong>cancer</strong> patients treated<br />

with X-rays or γ-rays. The level of <strong>cancer</strong><br />

risk after exposure to X-rays or γ-rays is<br />

modified by a number of factors in addition<br />

to radiation dose, and these include<br />

the age at which exposure occurs, the<br />

length of time over which radiation is<br />

received and the sex of the exposed person.<br />

Exposure to high-dose radiation<br />

increases the risk of leukaemia by over<br />

five-fold. Even higher relative risks have<br />

been <strong>report</strong>ed for thyroid <strong>cancer</strong> following<br />

irradiation during childhood.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!